21 Oct 2021 reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase Member news
20 Oct 2021 Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes Member news
15 Oct 2021 miDiagnostics to pilot innovative, fast COVID-19 PCR testing solutions at Brussels Airport Member news
13 Oct 2021 Oxurion NV announces first patient dosed in its Phase 2 Study evaluating THR-687 for the treatment of Diabetic Macular Edema (DME) Member news
12 Oct 2021 Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging Member news
12 Oct 2021 Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
